ROCKWELL MEDICAL, INC. Quarterly Selling and Marketing Expense in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Rockwell Medical, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2018 to Q2 2024.
  • Rockwell Medical, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $586K, a 10.6% increase year-over-year.
  • Rockwell Medical, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $2.28M, a 6.35% increase year-over-year.
  • Rockwell Medical, Inc. annual Selling and Marketing Expense for 2023 was $2.13M, a 1.48% increase from 2022.
  • Rockwell Medical, Inc. annual Selling and Marketing Expense for 2022 was $2.09M, a 63.5% decline from 2021.
  • Rockwell Medical, Inc. annual Selling and Marketing Expense for 2021 was $5.73M, a 27.2% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.28M $586K +$56K +10.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.22M $594K +$96K +19.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.13M $541K +$190K +54.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.94M $556K -$206K -27% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.14M $530K +$4K +0.76% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.14M $498K +$43K +9.45% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.09M $351K -$522K -59.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.62M $762K -$779K -50.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.4M $526K -$942K -64.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.34M $455K -$1.4M -75.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.73M $873K -$1.26M -59.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $6.99M $1.54M -$128K -7.67% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $7.12M $1.47M -$529K -26.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $7.65M $1.85M -$222K -10.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $7.87M $2.13M +$230K +12.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $7.64M $1.67M -$158K -8.65% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.8M $2M -$222K -10% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $8.02M $2.07M -$1.03M -33.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $9.05M $1.9M +$1.4M +278% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $7.65M $1.83M +$1.71M +1399% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.95M $2.22M +$2.05M +1250% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.89M $3.1M +$2.89M +1342% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1M $503K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $122K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $164K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $215K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.